BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32319385)

  • 21. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
    Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
    Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas].
    Wang QL; Huang HW; Jin ZM; Tang XW; Qiu HY; Fu CC; Han Y; Miao M; Chang HR; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):952-956. PubMed ID: 27995879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
    Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical Characteristics and Prognosis of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma].
    Zheng WS; Guan LX; Cheng LC; Hu YL; Peng B; Bo J; Wang QS; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1551-1557. PubMed ID: 33067953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gray zone lymphoma: five cases report and literature review].
    Zou HS; Zhang HJ; Liu HM; Huang WY; Liu W; Lyu R; Wang TY; Sui WW; Fu MW; Wang Q; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):242-246. PubMed ID: 37356987
    [No Abstract]   [Full Text] [Related]  

  • 27. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
    Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
    Ge Z; Liu Z; Hu X
    World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray-zone lymphoma. Examples of rare clinical manifestation.
    Misyurina AE; Kravchenko SK; Mangasarova YK; Magomedova AU; Kovrigina AM; Shimanovskaya LT; Fastova EA; Misyurin VA; Model SV; Chebotarev DI; Kostina IE; Savchenko VG
    Ter Arkh; 2019 May; 91(4):107-113. PubMed ID: 31094484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
    Bledsoe JR; Redd RA; Hasserjian RP; Soumerai JD; Nishino HT; Boyer DF; Ferry JA; Zukerberg LR; Harris NL; Abramson JS; Sohani AR
    Am J Hematol; 2016 Oct; 91(10):E436-41. PubMed ID: 27419920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autologous hematopoietic stem cell transplantation treatment for T cell lymphoblastic lymphoma].
    Wang P; Li CX; Zhang Y; Chen J; Chen XC; Yang D; Zhou J; Zong XP; Yang Z; Wu M; Yang MZ; Song YQ; Zhu J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):198-203. PubMed ID: 32311888
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.
    Tomassetti S; Chen R; Dandapani S
    Ther Adv Hematol; 2019; 10():2040620719841591. PubMed ID: 31040936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R; Boso C; Vianello F; Aversa MS; Chiarion-Sileni V; Trentin L; Zambello R; Muzzio PC; Fiore D; Sotti G
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):823-9. PubMed ID: 17379431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
    Forlenza CJ; Chadburn A; Giulino-Roth L
    J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma].
    Yi S; Liu W; Lyu R; Li Z; Xu Y; Sui W; Huang W; Wang T; Deng S; Liu H; Fu M; Zou D; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):546-50. PubMed ID: 24985182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
    Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and emerging treatment options in primary mediastinal B-cell lymphoma.
    Fakhri B; Ai W
    Ther Adv Hematol; 2021; 12():20406207211048959. PubMed ID: 34659697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.